Evidence map›Paper›PMID 18516617›Full record

ArticleEuropean journal of applied physiology2008

The effect of nitric oxide synthase and cyclooxygenase inhibition on cutaneous microvascular reactivity.

Helena Lenasi, Martin Strucl

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of applied physiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 44 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Association of coronary artery calcium score and vascular dysfunction in long-term hemodialysis patients.Hemodialysis international. International Symposium on Home Hemodialysis · 2013
    Article
  10. Review
  11. Article
  12. Aerobic training increases skin perfusion by a nitric oxide mechanism in type 2 diabetes.Diabetes, metabolic syndrome and obesity : targets and therapy · 2010
    Article
  13. Article
  14. Vascular pharmacology of epoxyeicosatrienoic acids.Advances in pharmacology (San Diego, Calif.) · 2010
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Helena LenasiInstitute of Physiology, School of Medicine, University of Ljubljana, Zaloska 4, Ljubljana, Slovenia. helena.lenasi.ml@mf.uni-lj.si
Martin Strucl
Institute of Oncology Ljubljana · SIUniversity of Ljubljana · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of nitric oxide (NO)- and prostacyclin (PGI(2))-independent mechanism, potentially attributable to endothelium-derived hyperpolarizing factor (EDHF), has not been extensively studied in human skin microcirculation. The aim of our study was to elucidate the contribution of the NO- and PGI(2)-independent mechanism to microvascular reactivity of cutaneous microcirculation. Skin perfusion was measured on the volar aspect of the forearm in 12 healthy male subjects (mean age 25.0 +/- 1.5), using laser Doppler (LD) fluxmetry. Combined endothelial nitric oxide synthase (eNOS) and cyclooxygenase (COX) inhibition was achieved by an intradermal injection (10 microl) of the eNOS inhibitor, L(omega)-monomethyl L-arginine (L-NMMA, 10 mM) and the COX inhibitor, diclofenac (10 mM); saline was injected as a control. LD flux was assessed at rest and after an iontophoretical application of acetylcholine (ACh, 1%), an endothelial agonist and sodium nitroprusside (SNP, 1%), an endothelium-independent agonist, respectively. Combined eNOS and COX inhibition had no effect on the baseline LDF (12.5 +/- 2.3 PU (perfusion units) in control vs. 10.9 +/- 1.8 PU in the treated site). On the other hand, the ACh-stimulated increase in LDF was significantly attenuated after eNOS and COX inhibition (390.5 +/- 43.5%), compared to the control (643.7 +/- 80.3% increase, t-test, P < 0.05). Nevertheless, at least 60% of ACh-mediated vasodilatation was preserved after combined eNOS and COX inhibition. eNOS and COX inhibition had no impact on the SNP-stimulated increase in LDF (768.8 +/- 70.5% in control vs. 733.5 +/- 54.6% in the treated site). These findings indicate that NO- and PGI(2)-independent mechanism plays an important role in the regulation of blood flow in the human skin microcirculation.

Indexed as

AcetylcholineAdultBiological FactorsBlood Flow VelocityCyclooxygenase InhibitorsDiclofenacEnzyme InhibitorsEpoprostenolForearmHumansInjections, IntradermalIontophoresisLaser-Doppler FlowmetryMaleMicrocirculationNitric OxideAcetylcholineBiological FactorsCyclooxygenase InhibitorsDiclofenacendothelium-dependent hyperpolarization factorEnzyme InhibitorsEpoprostenolNitric OxideNitric Oxide Synthase Type IIINitroprussideNOS3 protein, humanomega-N-MethylarginineVasodilator Agents

Identifiers

PMID18516617
OpenAlexW2049285930

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.